Brian Markison

Brian Markison

Chief Executive Officer chez LANTHEUS HOLDINGS, INC.

Fortune : 10 M $ au 31/03/2024

64 ans
Health Technology
Consumer Services
Commercial Services

Profil

Brian A.
Markison
is currently the Chief Executive Officer at Osmotica Pharmaceutical Corp.
He is also the Chief Executive Officer & Director at Lantheus Holdings, Inc. Additionally, he holds the position of Chief Executive Officer at RVL Pharmaceuticals, Inc. Mr. Markison is the Non-Executive Chairman at Lantheus Medical Imaging, Inc. He serves as a Director at The College of New Jersey, College of New Jersey Foundation, National Spine Center, The Pennington School, Komen Central & South Jersey, ACP Nimble Holdings, Inc., and Avista Capital Holdings LP.
In his former positions, Mr. Markison served as the Chairman, President & Chief Executive Officer at KP Pharmaceuticals LLC from 2004 to 2011.
He was also the President, Chief Executive Officer & Director at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
He held the position of Chairman & Chief Executive Officer at Osmotica Holdings Corp.
Ltd.
and RVL Pharmaceuticals Plc.
Mr. Markison was the CEO & Chairman at King Pharmaceuticals, Inc. He served as the Chairman at Rosetta Genomics Ltd.
from 2011 to 2018.
Additionally, he was the Executive Chairman at Vertical Pharmaceuticals LLC and Vertical.
Mr. Markison was the Lead Independent Outside Director at Immunomedics, Inc. and a Director at Alere, Inc. He also served as a Director at Theraclone Sciences, Inc., PharmAthene, Inc., National Spine & Pain Centers LLC, Braeburn, Inc., and Avista Healthcare Public Acquisition Corp.
Furthermore, he was a Director at Cosette Pharmaceuticals, Inc. Mr. Markison started his career at Bristol Myers Squibb Co. where he held the position of Senior VP-Operational Excellence & Productivity from 1982 to 2004.
He was also the President at Oncology Therapeutics Network Corp.
Mr. Markison obtained his undergraduate degree from Iona College in 1982.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/03/2024 152 826 ( 0,22% ) 10 M $ 31/03/2024
10/11/2023 2 338 242 ( 2,10% ) - $ 31/03/2024

Postes actifs de Brian Markison

SociétésPosteDébut
LANTHEUS HOLDINGS, INC. Chief Executive Officer 01/03/2024
College of New Jersey Foundation Director/Board Member -
Private Equity Investor 10/09/2012
Director/Board Member -
National Spine Center Director/Board Member -
Chief Executive Officer -
The College of New Jersey Director/Board Member -
Komen Central & South Jersey Director/Board Member -
Chairman 24/01/2013
░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Brian Markison

Anciens postes connus de Brian Markison

SociétésPosteFin
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Brian Markison

Formation de Brian Markison

Iona College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Brian Markison

Relations

99

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

ROSETTA GENOMICS LTD.

Health Technology

LANTHEUS HOLDINGS, INC.

Health Technology

RVL PHARMACEUTICALS PLC

Health Technology

Entreprise privées23

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Distribution Services

Finance

Health Technology

College of New Jersey Foundation

Health Technology

National Spine Center

Health Technology

Health Technology

Health Technology

Komen Central & South Jersey

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Distribution Services

King Pharmaceuticals, Inc.

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Brian Markison